DOMZALSKI DAVID (President and CEO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/3/2025ACC: 0001415889-25-015382
DirectorOfficer· President and CEO
Since Mar 2020
+8.68K
Net shares
Net buyer
$7.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.68K
Price / share
$0.81
Trade value
$7.03K
% of position
1.9%
6/2/2025
445.56K→454.24K
Total
Net shares
+8.68K
Net value
$7.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2025 | A · Award | +8.68K | $0.81 | $7.03K | 1.9% | 445.56K | 454.24K |
| Total | +8.68K | $7.03K | ||||||
Derivative Transactions0
No derivative transactions reported